Form 4: Merit Medical Systems Director David Floyd Reports Acquisition of Restricted Stock Units

Director David Floyd reports acquisition of 2,431 restricted stock units in Merit Medical Systems, Inc.

Summary

• On May 16, 2024, David Floyd, a director of Merit Medical Systems Inc. (MMSI), acquired 2,431 restricted stock units (RSUs) under the company's 2018 Long-Term Incentive Plan.
• The RSUs were granted at a price of $0 and will vest on May 16, 2025, contingent upon continued service to the issuer.
• Following the reported transaction, Floyd directly owns 8,881 shares of common stock and indirectly owns 1,584 shares through the David & Lisa Floyd Family LP and 5,964 shares through the David K. Floyd Living Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The RSU grant indicates confidence in the company's future performance and aligns the director's interests with shareholders. However, it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of the company.
• The vesting requirement of continued service encourages the director's ongoing commitment to the company.

Risks

• The value of the RSUs is subject to the performance of Merit Medical Systems' stock price.
• If the director ceases to provide service to the company before the vesting date, the RSUs will be forfeited.

Future Outlook

The RSUs will vest on May 16, 2025, contingent upon continued service to the issuer.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.
• Companies like Medtronic, Stryker, and Boston Scientific also utilize RSU grants as part of their executive compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• The director is incentivized to continue contributing to the company's growth and performance.

Key Dates